Form 4: Crown Castle EVP Kavanagh Disgorges Profits After Section 16(b) Violation

Sentiment:

SEC Form 4


Crown Castle's EVP & COO-Towers, Michael Joseph Kavanagh, reports purchases of common stock and agrees to disgorge profits due to a Section 16(b) violation.

Worse than expectedAn executive is required to disgorge profits due to a violation of Section 16(b) of the Securities Exchange Act.

Summary

  • Michael Joseph Kavanagh, EVP & COO-Towers at Crown Castle Inc., filed a Form 4 detailing changes in beneficial ownership.
  • The report indicates purchases of Crown Castle common stock on September 6, 7, and 8, 2022, at prices of $169.457, $172.665, and $173.378 respectively.
  • Kavanagh has agreed to voluntarily disgorge $508.11 to Crown Castle Inc. due to a Section 16(b) violation related to matchable transactions with a sale on April 29, 2022.
  • The purchases were executed by a third-party manager without Kavanagh's knowledge.
  • Following the reported transactions, Kavanagh beneficially owns 86,010 shares directly and 1,603 shares indirectly through a 401(k).

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the Section 16(b) violation, although the amount is relatively small. The fact that the purchases were made without the reporting person's knowledge mitigates the negativity somewhat.

Negatives

  • Kavanagh violated Section 16(b) of the Securities Exchange Act, requiring him to disgorge $508.11 in profits.

Risks

  • The Section 16(b) violation could raise concerns about internal controls and compliance procedures at Crown Castle.

Industry Context

Form 4 filings are routine disclosures for corporate insiders, but violations of Section 16(b) are less common and can draw scrutiny.

Stakeholder Impact

  • Shareholders may be concerned about the Section 16(b) violation, although the financial impact is minimal.

Key Dates

DateDescription
04/29/2022Date of common stock sale that was matchable under Section 16(b) with the reported purchases.
09/06/2022Date of first reported common stock purchase.
09/07/2022Date of second reported common stock purchase.
09/08/2022Date of third reported common stock purchase.
05/02/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.